Corporate Announcement
Security Code :
532296
Company :
GLENMARK
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Exchange Received Time
 09/07/2019 08:26:12
Exchange Disseminated Time
09/07/2019 08:26:15
Time Taken
00:00:03
Glenmark Pharmaceuticals receives ANDA approval for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg
Disclaimer
Back To Announcements